$11.74
0[0.00%]
At close: Apr 15
$11.74
0[0.00%]
PreMarket: 4:00PM EDT
KalVista Pharma
(NASDAQ:KALV)KalVista Pharma Stock (NASDAQ:KALV), Earnings Estimates, EPS, and Revenue
KalVista Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 11
EPS
$-0.840
Quarterly Revenue
$0K
Annual Revenue
(as of Jan 31)
(as of Jan 31)
–
Analyze the earnings history of KalVista Pharma using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 07/05/2024 | AM | KALV | Q4 | -$0.77 | — | — | — | $0.00 | — | — | — | Get Alert |
| 03/11/2024 | AM | KALV | Q3 | -$0.75 | -$0.77 | -$0.84 | -9.09% | $0.00 | — | $0.00 | — | Get Alert |
| 12/07/2023 | AM | KALV | Q2 | -$0.90 | -$0.79 | -$0.80 | -1.27% | $0.00 | — | $0.00 | — | Get Alert |
| 09/07/2023 | AM | KALV | Q1 | -$0.94 | -$0.86 | -$0.74 | 1395.35% | $0.00 | — | $0.00 | — | Get Alert |
| 07/07/2023 | AM | KALV | Q4 | -$0.98 | -$0.94 | -$0.77 | 18.09% | $0.00 | — | $0.00 | — | Get Alert |
| 03/09/2023 | AM | KALV | Q3 | -$0.92 | -$0.98 | -$0.75 | 23.47% | $0.00 | — | $0.00 | — | Get Alert |
| 12/08/2022 | AM | KALV | Q2 | -$0.80 | -$1.06 | -$0.90 | 15.09% | $0.00 | — | $0.00 | — | Get Alert |
| 09/08/2022 | AM | KALV | Q1 | -$0.66 | -$1.04 | -$0.94 | 9.62% | $0.00 | — | $0.00 | — | Get Alert |
| 07/07/2022 | AM | KALV | Q4 | -$0.65 | -$1.09 | -$0.98 | 10.09% | $0.00 | — | $0.00 | — | Get Alert |
| 03/10/2022 | AM | KALV | Q3 | -$0.56 | -$0.93 | -$0.92 | 1.08% | $0.00 | — | $0.00 | — | Get Alert |
| 12/09/2021 | AM | KALV | Q2 | -$0.58 | -$0.79 | -$0.80 | -1.27% | $0.00 | — | $0.00 | — | Get Alert |
| 09/09/2021 | AM | KALV | Q1 | -$0.61 | -$0.71 | -$0.66 | 7.04% | $0.00 | — | $0.00 | — | Get Alert |
| 07/13/2021 | AM | KALV | Q4 | -$0.37 | -$0.56 | -$0.65 | -16.07% | $3.82M | $580.00K | $0.00 | -100.00% | Get Alert |
| 03/11/2021 | AM | KALV | Q3 | -$0.52 | — | -$0.56 | — | $1.58M | — | $0.00 | — | Get Alert |
| 12/10/2020 | AM | KALV | Q2 | -$0.33 | — | -$0.58 | — | $3.92M | — | $0.00 | — | Get Alert |
| 09/14/2020 | AM | KALV | Q1 | -$0.42 | — | -$0.61 | — | $3.37M | — | $0.00 | — | Get Alert |
| 07/01/2020 | AM | KALV | Q4 | -$0.49 | — | -$0.37 | — | $2.93M | — | $3.82M | — | Get Alert |
| 03/10/2020 | AM | KALV | Q3 | -$0.23 | — | -$0.52 | — | $3.89M | — | $1.58M | — | Get Alert |
| 12/03/2019 | AM | KALV | Q2 | -$0.22 | — | -$0.33 | — | $5.59M | — | $3.92M | — | Get Alert |
FAQ
When is KalVista Pharma (NASDAQ:KALV) reporting earnings?
KalVista Pharma (KALV) is scheduled to report earnings on July 5, 2024. The last reported earnings were for reported on March 11, 2024 for Q3.
What were the latest earnings per share (EPS) for KalVista Pharma (NASDAQ:KALV)?
The Actual EPS was $-0.84, which missed the estimate of $-0.77.
What were KalVista Pharma’s (NASDAQ:KALV) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.